| pubmed-article:10987429 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10987429 | lifeskim:mentions | umls-concept:C0001648 | lld:lifeskim |
| pubmed-article:10987429 | lifeskim:mentions | umls-concept:C0039859 | lld:lifeskim |
| pubmed-article:10987429 | lifeskim:mentions | umls-concept:C1420841 | lld:lifeskim |
| pubmed-article:10987429 | lifeskim:mentions | umls-concept:C2698300 | lld:lifeskim |
| pubmed-article:10987429 | lifeskim:mentions | umls-concept:C0599740 | lld:lifeskim |
| pubmed-article:10987429 | lifeskim:mentions | umls-concept:C0053169 | lld:lifeskim |
| pubmed-article:10987429 | pubmed:issue | 17 | lld:pubmed |
| pubmed-article:10987429 | pubmed:dateCreated | 2001-1-4 | lld:pubmed |
| pubmed-article:10987429 | pubmed:abstractText | A series of thiazole benzenesulfonamide-substituted 3-pyridylethanolamines was prepared and evaluated for their human beta3 adrenergic receptor agonist activity. Incorporation of aryl and heteroaryl substitution in the 4-position of the thiazole ring resulted in a number of highly potent and selective beta3 agonists. Results of preliminary in vivo evaluation of several of these compounds is described. | lld:pubmed |
| pubmed-article:10987429 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10987429 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10987429 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10987429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10987429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10987429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10987429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10987429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10987429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10987429 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10987429 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:10987429 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:10987429 | pubmed:author | pubmed-author:MacIntyreD... | lld:pubmed |
| pubmed-article:10987429 | pubmed:author | pubmed-author:DenkHH | lld:pubmed |
| pubmed-article:10987429 | pubmed:author | pubmed-author:FisherM HMH | lld:pubmed |
| pubmed-article:10987429 | pubmed:author | pubmed-author:CascieriM AMA | lld:pubmed |
| pubmed-article:10987429 | pubmed:author | pubmed-author:TothKK | lld:pubmed |
| pubmed-article:10987429 | pubmed:author | pubmed-author:FeeneyW PWP | lld:pubmed |
| pubmed-article:10987429 | pubmed:author | pubmed-author:IRAG HGH | lld:pubmed |
| pubmed-article:10987429 | pubmed:author | pubmed-author:ForrestM JMJ | lld:pubmed |
| pubmed-article:10987429 | pubmed:author | pubmed-author:WeberA EAE | lld:pubmed |
| pubmed-article:10987429 | pubmed:author | pubmed-author:CandeloreM... | lld:pubmed |
| pubmed-article:10987429 | pubmed:author | pubmed-author:ChittyDD | lld:pubmed |
| pubmed-article:10987429 | pubmed:author | pubmed-author:WyvrattM JMJ | lld:pubmed |
| pubmed-article:10987429 | pubmed:author | pubmed-author:MathvinkR JRJ | lld:pubmed |
| pubmed-article:10987429 | pubmed:author | pubmed-author:ColwellL... | lld:pubmed |
| pubmed-article:10987429 | pubmed:author | pubmed-author:TolmanJ SJS | lld:pubmed |
| pubmed-article:10987429 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10987429 | pubmed:day | 4 | lld:pubmed |
| pubmed-article:10987429 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:10987429 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10987429 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10987429 | pubmed:pagination | 1971-3 | lld:pubmed |
| pubmed-article:10987429 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:10987429 | pubmed:meshHeading | pubmed-meshheading:10987429... | lld:pubmed |
| pubmed-article:10987429 | pubmed:meshHeading | pubmed-meshheading:10987429... | lld:pubmed |
| pubmed-article:10987429 | pubmed:meshHeading | pubmed-meshheading:10987429... | lld:pubmed |
| pubmed-article:10987429 | pubmed:meshHeading | pubmed-meshheading:10987429... | lld:pubmed |
| pubmed-article:10987429 | pubmed:meshHeading | pubmed-meshheading:10987429... | lld:pubmed |
| pubmed-article:10987429 | pubmed:meshHeading | pubmed-meshheading:10987429... | lld:pubmed |
| pubmed-article:10987429 | pubmed:meshHeading | pubmed-meshheading:10987429... | lld:pubmed |
| pubmed-article:10987429 | pubmed:meshHeading | pubmed-meshheading:10987429... | lld:pubmed |
| pubmed-article:10987429 | pubmed:meshHeading | pubmed-meshheading:10987429... | lld:pubmed |
| pubmed-article:10987429 | pubmed:meshHeading | pubmed-meshheading:10987429... | lld:pubmed |
| pubmed-article:10987429 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10987429 | pubmed:articleTitle | Potent, selective 3-pyridylethanolamine beta3 adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophore. | lld:pubmed |
| pubmed-article:10987429 | pubmed:affiliation | Department of Medicinal Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA. robert_mathvink@merck.com | lld:pubmed |
| pubmed-article:10987429 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:10987429 | lld:chembl |
